To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Bill Documents
30 Apr 2024 - Amendment Paper
Public Bill Committee Amendments as at 30 April 2024
Tobacco and Vapes Bill 2023-24

Found: Committee shall hear oral evidence in accordance with the following Table: Witness Time Date Cancer


Bill Documents
30 Apr 2024 - Bill proceedings: Commons
All proceedings up until 30 April 2024 at Public Bill Committee Stage
Tobacco and Vapes Bill 2023-24

Found: Committee shall hear oral evidence in accordance with the following Table: Witness Time Date Cancer


Written Question
Leukaemia
Tuesday 30th April 2024

Asked by: Julian Sturdy (Conservative - York Outer)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps she is taking to increase awareness of acute myeloid leukaemia.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

Raising awareness and improving early diagnosis of cancer, including blood related cancers such as acute myeloid leukaemia, remains a priority for the Government. NHS England is taking steps to raise awareness of all cancers, and in January 2024, relaunched the Help Us Help You cancer awareness campaign, designed to increase earlier diagnosis of cancer by reducing barriers to seeking help, as well as increasing body awareness, and knowledge of key red flag symptoms. This campaign addresses barriers to people coming forward with suspected signs of all cancers.

This relaunch follows NHS England’s initial launch of the Help Us Help You campaign in April 2020, a major public information campaign to persuade the public to seek urgent care and treatment when they need it. The Help Us Help You strategy is designed to address the underlying barriers to cancer diagnosis, including multifaceted fears, a lack of body awareness, and a lack of knowledge of cancer symptoms, to encourage people to present earlier.


Written Question
Liver Cancer: Mortality Rates
Tuesday 30th April 2024

Asked by: Gregory Campbell (Democratic Unionist Party - East Londonderry)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether she has made an estimate of expected liver cancer mortality rates by the end of 2025.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

No estimate has been made of expected liver cancer mortality rates by the end of 2025. The care of and treatment for patients with cancer, including liver cancer, is a priority for the Government. Early diagnosis of liver cancer is critical to improving rates of survival. NHS England’s Early Diagnosis of Liver Cancer Programme is contributing to the NHS Long Term Plan’s commitment to diagnose 75% of all cancers at stage one or two by 2028. This programme includes three workstreams: improving liver surveillance programmes; community liver health checks pilots; and primary care pilots. Identifying those at risk and ensuring patients are tested and referred to a surveillance programme, where necessary, will lead to improved patient outcomes.


Written Question
Stepping Hill Hospital: Bowel Cancer
Tuesday 30th April 2024

Asked by: Navendu Mishra (Labour - Stockport)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent assessment her Department has made of the adequacy of (a) diagnosis and (b) treatment services for bowel cancer at Stepping Hill hospital.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

No specific assessment has been made of the adequacy of diagnosis and treatment services for bowel cancer at Stepping Hill Hospital. However, data held at the provider level can give us insight into lower gastrointestinal (GI) cancer for Stockport NHS Foundation Trust. Of those patients referred to Stockport NHS Foundation Trust for suspected lower GI cancer in February 2024, 86.1% received a diagnosis or ruling out of cancer within 28 days. This is above the 75.0% standard, and shows an increase of 4.2% since January. Furthermore, of those patients referred to Stockport NHS Foundation Trust for lower GI cancer in February 2024, 95.2% received a first or subsequent treatment within 31 days of a decision to treat. This is above national performance of 91.1%, against the standard of 96.0%. For lower GI cancer in the same period, 67.4% of patients received treatment within 62 days of an urgent suspected cancer or screening referral, or consultant upgrade, to a first definitive treatment for cancer. This is above national performance of 63.9% against the standard of 85.0%.


Departmental Publication (Open consultation)
Department for Work and Pensions

Apr. 29 2024

Source Page: Modernising support for independent living: the health and disability green paper
Document: Evidence pack: Modernising support for independent living: the health and disability green paper (PDF)

Found: • Highest overall award rates are seen for conditions including Cancer, Autistic Spectrum Disorders


Departmental Publication (Open consultation)
Department for Work and Pensions

Apr. 29 2024

Source Page: Modernising support for independent living: the health and disability green paper
Document: (Excel)

Found: This includes: - Psychotic Disorders - Cancer - Skin Diseases - Chronic Pain Syndromes - Gastrointestinal


Non-Departmental Publication (News and Communications)
Medicines and Healthcare products Regulatory Agency

Apr. 29 2024

Source Page: Letters and medicine recalls sent to healthcare professionals in March 2024
Document: GAVRETO®▼(pralsetinib): Planned transition of Market Authorisation Holder for GAVRETO®▼(pralsetinib) from Roche Products Ltd to BluePrint Medicines resulting in discontinuation of supply from Roche Products Ltd (PDF)

Found: prescribers seek alternative treatment options for newly identified metastatic non-small cell lung cancer



Westminster Hall
Assisted Dying - Mon 29 Apr 2024
Home Office

Mentions:
1: David Davis (Con - Haltemprice and Howden) Some time ago—a long time ago—my mother died of brain and lung cancer in considerable agony, pain and - Speech Link
2: Jim Shannon (DUP - Strangford) Gentleman for his intervention, but I will give him the example of a lady over 70 who has cancer and - Speech Link
3: Lia Nici (Con - Great Grimsby) Debbie had terminal cancer; tumours meant that she could not swallow or digest food any more. - Speech Link
4: Jane Hunt (Con - Loughborough) Having been diagnosed with bowel cancer last year, I know that doctors already provide an option. - Speech Link